key: cord-1038101-bwhi4hcl
authors: Shoji, Hamilton; Fonseca, Eduardo Kaiser Ururahy Nunes; Teles, Gustavo Borges da Silva; Passos, Rodrigo Bastos Duarte; Yanata, Elaine; Silva, Murilo Marques Almeida; Funari, Marcelo Buarque de Gusmão; Sasdelli, Roberto; Ishikawa, Walther Yoshiharu; Chate, Rodrigo Caruso; Szarf, Gilberto
title: Structured thoracic computed tomography report for COVID-19 pandemic
date: 2020-04-03
journal: Einstein
DOI: 10.31744/einstein_journal/2020ed5720
sha: 177a6a35f4f7c31f93d3a6d7011321215d6e6e05
doc_id: 1038101
cord_uid: bwhi4hcl

nan

By the end of 2019, a novel coronavirus (severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2) was identified as the etiologic agent of an outbreak of pneumonia in the city of Wuhan, province of Hubei, in China. The virus had a rapid dissemination, with person-to-person transmission and cases soon identified throughout the world. The disease was called COVID-19 (coronavirus disease 2019), with several new outbreaks related to community transmission. It is now classified as pandemic. (1) (2) (3) (4) We have observed an increase in requests of chest computed tomography (CT) since the first records of cases in Brazil; therefore, in a near future, the current installed capacity of the system to analyze and produce the CT reports may be exceeded. It is crucial to highlight that the definite diagnosis of COVID-19 is made by real-time polymerase chain reaction (RT-PCR), and a normal (negative) chest CT does not rule out diagnosis. However, currently, the RT-PCR result has taken longer than CT reports to be available, so CT has taken an important role in a comprehensive assessment of patients, for demonstrating high sensitivity (although low specificity), to detect the most frequent pulmonary findings of the disease.

In this high demand urgency context to provide results, it is advisable that the content of the radiological report be very objective and as clear as possible for the requesting physicians from the emergency department. The most relevant pieces of information to be conveyed are presence (or not) of pulmonary involvement, if the findings are compatible with infectious process, and, in positive cases, if the changes are suggestive of viral etiology, particularly COVID-19, even if there is overlapping of findings with other infectious diseases (including other viruses). We also included an approximate estimate of extent of pulmonary involvement by the disease (visual analysis), which has been considered useful by them in management of patients, together with other clinical data and physical examination. In our Institution, involvement of >50% of parenchyma (5) has been used as an additional criterion to decide for hospitalization.

In a structured report, we initially describe if there are pulmonary changes or not, and if they are suggestive of a pulmonary infectious process. In case einstein (São Paulo). 2020;18:1-3

Shoji H, Fonseca EK, Teles GB, Passos RB, Yanata E, Silva MM, Funari MB, Sasdelli Neto R, Ishikawa WY, Chate RC, Szarf G of alterations, if the features are in accordance or not with the more typical pattern described in COVID-19: including ground-glass opacities, sometimes with superimposed interlobular septal thickening (crazy paving), consolidations and reversed halo, presenting a bilateral multilobar distribution, predominantly peripheral, with mild predilection for the posterior regions and lower lobes. (6) (7) (8) (9) (10) In these cases, we have highlighted in our reports that "the possibility of COVID-19 should be considered in the differential diagnoses", and also included the estimated extent of parenchyma involvement (greater or lesser than 50%). (5) Figure 1 shows a case with typical imaging findings of COVID-19 and the model of provided report.

In patients with tomographic findings more suggestive of other type of infection which obviously must not be neglected amidst the pandemic, we have described the changes and concluded as follows: "Such findings are compatible with pulmonary infectious process, and its characteristics are not typically observed in cases of pulmonary involvement by COVID-19; other etiologic agents should be initially considered in the differential diagnosis." As examples of changes described in the literature as uncommon in cases of COVID-19, which increase the probability of infection by other agents, we underline numerous centrilobular micronodules with tree-in-bud pattern, relatively welldefined solid nodules, cavities, predominant central parenchyma involvement, mainly affecting the airways. (6) (7) (8) (9) Figure 2 displays an example of one of those cases and its respective report, with final diagnosis of tuberculosis after complete investigation. Computed tomography images of a case with initial clinical suspicion of COVID-19 and its respective report, with tomographic findings suggestive of infectious process, but with characteristics that are not usual in COVID-19. After performing ancillary investigations, the diagnosis was pulmonary tuberculosis

In the subgroup of patients with no tomographic evidence of pulmonary infectious process, we clearly and explicitly report the following phrase: "Absence of focal pulmonary opacities suggestive of active parenchymal infectious process."

Next, other additional relevant findings are briefly included, emphasizing the presence or not of lymph node enlargement, pleural effusion, as well as pulmonary nodules, emphysema, chronic interstitial disease, aneurysms and marked atheromatous disease.

Developing structured reports in radiology, primarily those oriented to certain diseases, provides several benefits, including clarity in conveying information to requesting physicians and use of a common terminology, enabling all those involved to be familiar with specific terms used for each disease. Moreover, this later enables collecting data for epidemiological purposes, quality control and research. (11, 12) Other advantages comprise increased radiologist productivy with less burden. (12) Implementing a structured report should be beneficial, particularly in the current scenario of COVID-19 pandemic, for increasing productivity of radiologists and enabling better understanding of the requesting physicians, with a potential positive impact in management of patients. (13) 

National Health Commission of the People's Republic of China

Novel Coronavirus -Republic of Korea (ex-China)

Geographical distribution of 2019-nCov cases. Situation update worldwide

COVID-19). Cases in U.S [Internet

Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study

Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT

Imaging profile of the covid-19 infection: radiologic findings and literature review

CT Imaging Features of 2019 Novel coronavirus (2019-nCoV)

Chest Imaging Appearance of COVID-19 Infection

Electronic address: https: // www.lancovid.org. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis

Benefits of the DICOM structured report

Structured Reporting in Radiology

Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA